Luis Quiñones
Universidad de Chile
H-index: 26
Latin America-Chile
Top articles of Luis Quiñones
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Exploring the impact of MiR-92a-3p on FOLFOX chemoresistance biomarker genes in colon cancer cell lines | Frontiers in Pharmacology | Paula I Escalante Luis A Quiñones Héctor R Contreras | 2024/4/10 |
Assessing the Occurrence and Influence of Cancer Chemotherapy-Related Pharmacogenetic Alleles in the Chilean Population | Pharmaceutics | Gareth I Owen Miguel Cordova-Delgado Bernabé I Bustos Leslie C Cerpa Pamela Gonzalez | 2024/4 |
Genetic Polymorphisms and Tumoral Mutational Profiles over Survival in Advanced Colorectal Cancer Patients: An Exploratory Study | Current Oncology | Juan Pablo Cayún Leslie Carol Cerpa Alicia Colombo Dante Daniel Cáceres José Luis Leal | 2024/1/3 |
Editor’s feature: negative findings in pharmacogenetics and pharmacogenomics | Frontiers in Pharmacology | José AG Agúndez Pedro Ayuso Luis A Quiñones Elena García-Martín | 2023/8/8 |
An updated examination of the perception of barriers for pharmacogenomics implementation and the usefulness of drug/gene pairs in Latin America and the Caribbean | Frontiers in Pharmacology | Aimeé Salas-Hernández Macarena Galleguillos Matías Carrasco Andrés López-Cortés María Ana Redal | 2023/5/11 |
Pharmacogenetics and pharmacogenomics in Latin America: ethnic variability, new insights in advances and perspectives: a RELIVAF-CYTED initiative, Volume II | Andrés López-Cortés Patricia Esperón Matías F Martínez María A Redal Alberto Lazarowski | 2023/5/3 | |
Pharmacogenomics and ethnicity: Prevalence and clinical significance of pharmacogenomic biomarkers in indigenous and other populations | Frontiers in Pharmacology | George P Patrinos Luis Abel Quinones Chonlaphat Sukasem | 2023/3/29 |
Cohort Profile of the Chilean COVID-19 Biorepository: a Multicentric initiative for multi-omics research on COVID-19 and LONG-COVID in a Latin American population. | medRxiv | Iskra A Signore Gerardo Donoso Pamela Bocchieri Eduardo A Tobar-Calfucoy Cristian E Yanez | 2023 |
A second update on mapping the human genetic architecture of COVID-19 | Nature | Masahiro Kanai Shea J Andrews Mattia Cordioli Christine Stevens Benjamin M Neale | 2023/9/7 |
Clinical and pulmonary function analysis in long-COVID revealed that long-term pulmonary dysfunction is associated with vascular inflammation pathways and metabolic syndrome | Frontiers in Medicine | Sergio Sanhueza Mabel A Vidal Mauricio A Hernandez Mario E Henriquez-Beltran Camilo Cabrera | 2023 |
Background: Efavirenz (EFV), a non-nucleoside reverse transcriptase inhibitor, and atazanavir (ATV), a protease inhibitor, are drugs widely used in antiretroviral therapy (ART … | Pharmacogenetics and Pharmacogenomics in Latin America: Ethnic Variability, New Insights in Advances and Perspectives: A RELIVAF-CYTED Initiative | Daniela Poblete Fernando Bernal Gabriel Llull Sebastian Archiles Patricia Vasquez | 2022/2/17 |
Background: There is pressing urgency to identify therapeutic targets and drugs that allow treating COVID-19 patients effectively. Methods: We performed in silico analyses of … | Chemoinformatics Approaches to Structure-and Ligand-Based Drug Design, Volume II | Andrés López-Cortés Patricia Guevara-Ramírez Nikolaos C Kyriakidis Carlos Barba-Ostria Ángela León Cáceres | 2022/7/27 |
Jan Grzegorzewski*, Janosch Brandhorst and Matthias König | Luis Abel Quiñones Ismael Lares-Asseff Zifei Qin | 2022 | |
Pharmacokinetic Polymorphisms | Matías F Martínez Leslie C Cerpa Nelson M Varela Luis A Quiñones | 2022/6/15 | |
Pharmacogenomics: Basis and milestones | Leslie C Cerpa Nelson M Varela Matías M Martínez Luis A Quiñones | 2022/6/15 | |
Pulmonary inflammatory response in lethal COVID-19 reveals potential therapeutic targets and drugs in phases III/IV clinical trials | Frontiers in Pharmacology | Andrés López-Cortés Santiago Guerrero Esteban Ortiz-Prado Verónica Yumiceba Antonella Vera-Guapi | 2022/3/29 |
A New Insight for the Identification of Oncogenic Variants in Breast and Prostate Cancers in Diverse Human Populations, With a Focus on Latinos. Front. Pharmacol. 12: 630658 … | Frontiers in Pharmacology| www. frontiersin. org | NM Varela P Guevara-Ramírez C Acevedo T Zambrano I Armendáriz-Castillo | 2021/4/12 |
Smartphone screen testing, a novel pre-diagnostic method to identify SARS-CoV-2 infectious individuals | Elife | Rodrigo M Young Camila J Solis Andres Barriga-Fehrman Carlos Abogabir Alvaro R Thadani | 2021/6/22 |
NOD1 rs2075820 (p.E266K) polymorphism is associated with gastric cancer among individuals infected with cagPAI-positive H. pylori | Biological Research | Patricio Gonzalez-Hormazabal Diana Pelaez Maher Musleh Marco Bustamante Juan Stambuk | 2021/12 |
Pharmacogenomics: Genetic polymorphisms | Nelson M Varela Leslie C Cerpa Matías M Martínez Luis A Quiñones | 2021/9/14 |
Co-Authors
